356 related articles for article (PubMed ID: 24802387)
21. A negatively charged transmembrane aspartate residue controls activation of the relaxin-3 receptor RXFP3.
Liu Y; Zhang L; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2016 Aug; 604():113-20. PubMed ID: 27353281
[TBL] [Abstract][Full Text] [Related]
22. The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity.
Patil NA; Bathgate RAD; Kocan M; Ang SY; Tailhades J; Separovic F; Summers R; Grosse J; Hughes RA; Wade JD; Hossain MA
Amino Acids; 2016 Apr; 48(4):987-992. PubMed ID: 26661035
[TBL] [Abstract][Full Text] [Related]
23. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
24. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
25. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
26. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3.
Summers RJ; Bathgate RA; Wade JD; van der Westhuizen ET; Halls ML
Ann N Y Acad Sci; 2009 Apr; 1160():99-104. PubMed ID: 19416167
[TBL] [Abstract][Full Text] [Related]
27. Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
Sethi A; Bruell S; Ryan T; Yan F; Tanipour MH; Mok YF; Draper-Joyce C; Khandokar Y; Metcalfe RD; Griffin MDW; Scott DJ; Hossain MA; Petrie EJ; Bathgate RAD; Gooley PR
J Mol Biol; 2021 Oct; 433(21):167217. PubMed ID: 34454945
[TBL] [Abstract][Full Text] [Related]
28. C-terminus of the B-chain of relaxin-3 is important for receptor activity.
Shabanpoor F; Bathgate RA; Wade JD; Hossain MA
PLoS One; 2013; 8(12):e82567. PubMed ID: 24349312
[TBL] [Abstract][Full Text] [Related]
29. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
30. Modeling the primary hormone-binding site of RXFP1 and RXFP2.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162
[TBL] [Abstract][Full Text] [Related]
31. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
32. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
Scott DJ; Rosengren KJ; Bathgate RA
Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
[TBL] [Abstract][Full Text] [Related]
33. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
[TBL] [Abstract][Full Text] [Related]
34. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
[TBL] [Abstract][Full Text] [Related]
35. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
36. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
37. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
[TBL] [Abstract][Full Text] [Related]
38. Structural properties of relaxin chimeras.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
[TBL] [Abstract][Full Text] [Related]
39. Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin.
Bruell S; Sethi A; Smith N; Scott DJ; Hossain MA; Wu QP; Guo ZY; Petrie EJ; Gooley PR; Bathgate RAD
Sci Rep; 2017 Jun; 7(1):3294. PubMed ID: 28607406
[TBL] [Abstract][Full Text] [Related]
40. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
